- $43.27m
- -$29.44m
- $0.28m
- 63
- 41
- 36
- 44
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.41 | ||
Price to Tang. Book | 0.44 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 157.34 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -12.64% | ||
Return on Equity | 2.2% | ||
Operating Margin | -4729.82% |
Financial Summary
Year End 31st Jul | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 4.93 | 4.91 | 0.8 | 0.41 | 0.28 | n/a | n/a | -42.32% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
Directors
- Howard Jonas CHM (65)
- Patrick Fabbio PRE (54)
- William Conkling CEO (50)
- Ashok Marin OTH (53)
- David Polinsky OTH (50)
- Stephen Greenberg LED (77)
- Rachel Jonas DRC (28)
- Shannon Klinger DRC (50)
- Ameet Mallik DRC (49)
- Mark McCamish DRC (69)
- Boris Pasche IND (60)
- Michael Weiss IND (70)
- Last Annual
- July 31st, 2023
- Last Interim
- January 31st, 2024
- Incorporated
- July 27th, 2017
- Public Since
- March 12th, 2018
- No. of Shareholders
- 263
- No. of Employees
- 13
- Sector
- Real Estate Operations
- Industry
- Financials
- Exchange
- New York Stock Exchange
- Shares in Issue
- 24,584,439
- Address
- 520 Broad St, NEWARK, 07120
- Web
- https://rafaelholdings.com
- Phone
- +1 2126581450
- Auditors
- CohnReznick LLP
Upcoming Events for RFL
Similar to RFL
American Realty Investors
New York Stock Exchange
American Strategic Investment Co
New York Stock Exchange
Anywhere Real Estate
New York Stock Exchange
Brookfield Business Partners LP
New York Stock Exchange
CBRE
New York Stock Exchange
FAQ
As of Today at 19:17 UTC, shares in Rafael Holdings are trading at $1.76. This share price information is delayed by 15 minutes.
Shares in Rafael Holdings last closed at $1.76 and the price had moved by -9.28% over the past 365 days. In terms of relative price strength the Rafael Holdings share price has underperformed the S&P500 Index by -24.51% over the past year.
There is no consensus recommendation for this security.
Rafael Holdings does not currently pay a dividend.
Rafael Holdings does not currently pay a dividend.
Rafael Holdings does not currently pay a dividend.
To buy shares in Rafael Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.76, shares in Rafael Holdings had a market capitalisation of $43.27m.
Here are the trading details for Rafael Holdings:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: RFL
Based on an overall assessment of its quality, value and momentum Rafael Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rafael Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -11.59%.
As of the last closing price of $1.76, shares in Rafael Holdings were trading -6.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rafael Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rafael Holdings' management team is headed by:
- Howard Jonas - CHM
- Patrick Fabbio - PRE
- William Conkling - CEO
- Ashok Marin - OTH
- David Polinsky - OTH
- Stephen Greenberg - LED
- Rachel Jonas - DRC
- Shannon Klinger - DRC
- Ameet Mallik - DRC
- Mark McCamish - DRC
- Boris Pasche - IND
- Michael Weiss - IND